RL

Richa Laxman Gupta

Active Director Director DIN 10599157
DIN 10599157 First appointment Apr 2024 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Richa Laxman Gupta

Data last updated:

Richa Laxman Gupta is a Director at Ambrosine Pharma Private Limited (since 2024). The company operates in Paper.

DIN 10599157
Primary Designation Director
Industry Paper
First Appointment 22 Apr 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ambrosine Pharma Private Limited U21002MH2024PTC423851
Director22 Apr 20242024Active

Board colleagues of Richa Laxman Gupta

NameDINCompanyDesignation
Isha Dipak Deotale10647299Ambrosine Pharma Private LimitedIndividual Subscriber
Sunanda Umaji Padole07928453Ambrosine Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Ambrosine Pharma Private Limited
Premium access

Shareholding and investment profile for Richa Laxman Gupta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Richa Laxman Gupta

Richa Laxman Gupta currently holds 1 directorship: Ambrosine Pharma Private Limited (Director, since 22 Apr 2024).

Richa Laxman Gupta was first appointed on 22 Apr 2024 as Director at Ambrosine Pharma Private Limited.

The current boards of Richa Laxman Gupta's companies include Isha Dipak Deotale (Ambrosine Pharma Private Limited), Sunanda Umaji Padole (Ambrosine Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available